Diagnosis and management of meningococcal disease: the need for centralized care: Figure 1
Open Access
- 1 January 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 31 (1) , 71-83
- https://doi.org/10.1111/j.1574-6976.2006.00059.x
Abstract
Meningococcal infection remains a significant health problem in children, with a significant mortality and morbidity. Prompt recognition and aggressive early treatment are the only effective measures against invasive disease. This requires immediate administration of antibiotic therapy, and the recognition and treatment of patients who may have complications of meningococcal infection such as shock, raised intracranial pressure (ICP) or both. Encouragingly, its mortality has fallen in recent years. This is the result of several factors such as the centralization of care of seriously ill children in paediatric intensive care units (PICUs), the establishment of specialized mobile intensive care teams, the development of protocols for the treatment of meningococcal infection, and the dissemination by national bodies and charities of guidance about early recognition and management. We will review the pathophysiology and management of the different presentations of meningococcal disease and examine the possible role of adjunctive therapies.Keywords
This publication has 92 references indexed in Scilit:
- Emergence of Non-Ceftriaxone-Susceptible Neisseria meningitidis in IndiaJournal of Clinical Microbiology, 2006
- THE EFFICACY OF DROTRECOGIN ALFA (ACTIVATED) FOR THE TREATMENT OF PEDIATRIC SEVERE SEPSIS.Critical Care Medicine, 2005
- The interactions between inflammation and coagulationBritish Journal of Haematology, 2005
- Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Critical Care Medicine, 2004
- Dysfunction of Endothelial Protein C Activation in Severe Meningococcal SepsisNew England Journal of Medicine, 2001
- Randomized, Placebo‐Controlled Trial of HA‐1A, a Human Monoclonal Antibody to Endotoxin, in Children with Meningococcal Septic ShockClinical Infectious Diseases, 1999
- Variation in the Tumor Necrosis Factor- Gene Promoter Region May Be Associated with Death from Meningococcal DiseaseThe Journal of Infectious Diseases, 1996
- COMPLEMENT DEFICIENCIES IN PATIENTS OVER TEN YEARS OLD WITH MENINGOCOCCAL DISEASE DUE TO UNCOMMON SEROGROUPSThe Lancet, 1989
- Complement Deficiencies in Selected Groups of Patients with Meningococcal DiseaseScandinavian Journal of Infectious Diseases, 1989
- Factors in the prognosis ofmeningococcal infectionThe Journal of Pediatrics, 1966